MASSBIOLOGICS
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1894-01-01
- Employees
- 251
- Market Cap
- -
First Clinical Study of the Safety and Blood Levels of a Human Monoclonal Antibody (2217LS) Against Lyme Disease Bacteria in Healthy People
- Conditions
- Lyme Disease
- Interventions
- Other: 0.9% Sodium Chloride (NaCl)Biological: 2217LS
- First Posted Date
- 2021-04-28
- Last Posted Date
- 2022-09-16
- Lead Sponsor
- MassBiologics
- Target Recruit Count
- 44
- Registration Number
- NCT04863287
- Locations
- 🇺🇸
Celerion Inc., Lincoln, Nebraska, United States
Evaluate the Safety Pharmacokinetics of a Human Monoclonal Antibody S315 Against Diphtheria Toxin in Healthy Subjects
- First Posted Date
- 2019-08-30
- Last Posted Date
- 2020-02-05
- Lead Sponsor
- MassBiologics
- Target Recruit Count
- 41
- Registration Number
- NCT04075175
- Locations
- 🇺🇸
Parexel Early Phase Clinical Unit, Baltimore, Maryland, United States
Open Label Study of the Efficacy and Safety of MBL-HCV1 in Combination With Oral Direct-Acting Antivirals in Patients Undergoing Liver Transplantation for Hepatitis C
- Conditions
- Hepatitis C Infection
- Interventions
- First Posted Date
- 2012-02-15
- Last Posted Date
- 2021-02-05
- Lead Sponsor
- MassBiologics
- Target Recruit Count
- 11
- Registration Number
- NCT01532908
- Locations
- 🇺🇸
Mount Sinai Hospital, New York, New York, United States
🇺🇸Washington University School of Medicine, Saint Louis, Missouri, United States
🇺🇸The Liver Institute at Methodist Dallas Medical Center, Dallas, Texas, United States
Study in Hepatitis C Virus (HCV) Infected Patients Undergoing Liver Transplantation to Evaluate a Human Monoclonal Antibody Against Hepatitis C
- Conditions
- HCV InfectionLiver Transplantation
- Interventions
- Biological: MBL-HCV1Other: 0.9% Sodium chloride Placebo
- First Posted Date
- 2010-05-12
- Last Posted Date
- 2016-06-14
- Lead Sponsor
- MassBiologics
- Target Recruit Count
- 13
- Registration Number
- NCT01121185
- Locations
- 🇺🇸
Lahey Clinic, Burlington, Massachusetts, United States
🇺🇸Cleveland Clinic Foundation, Cleveland, Ohio, United States
🇺🇸Mount Sinai Hospital, New York, New York, United States
Study in Healthy Volunteers to Evaluate a Human Monoclonal Antibody Against Hepatitis C
- Conditions
- Healthy
- Interventions
- Biological: MBL-HCV1
- First Posted Date
- 2009-08-06
- Last Posted Date
- 2016-09-15
- Lead Sponsor
- MassBiologics
- Target Recruit Count
- 31
- Registration Number
- NCT00952263
- Locations
- 🇺🇸
DaVita Clinical Research, Minneapolis, Minnesota, United States
Study of the Clinical Effectiveness of a Human Monoclonal Antibody to C. Difficile Toxin A and Toxin B in Patients With Clostridium Difficile Associated Disease
- Conditions
- Clostridium Infections
- Interventions
- Biological: GS-CDA1/MDX-1388Biological: normal saline
- First Posted Date
- 2006-07-10
- Last Posted Date
- 2021-02-09
- Lead Sponsor
- MassBiologics
- Target Recruit Count
- 200
- Registration Number
- NCT00350298
- Locations
- 🇺🇸
Saint James Healthcare, Butte, Montana, United States
🇺🇸Rapid City Regional Hospital, Rapid City, South Dakota, United States
🇺🇸Jersey Shore University Medical Center, Neptune, New Jersey, United States